iShares U.S. Pharmaceuticals ETF (IHE)

Delayed Data
As of Jan 21
 -1.52 / -0.81%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.


1 month-5.23% 3 years+9.68%
3 months+0.40% 5 years+7.32%
1 year+3.25% Since inception+10.28%
Data through 01/22/2022

Quote Details

Previous close$188.43
Open day’s range186.81 – 187.38
Net asset value (NAV)186.36 (01/21/2022)
Daily volume5,500
Average volume (3 months)7,422
Data as of 3:48pm ET, 01/21/2022

Peer Comparisonvs. Health ETFs

Performance 5-yr return+7.32%+15.55%
Expense Gross exp ratio0.42%1.01%
Risk 5 year sharpe ratio0.540.85
Net assets$399.0M$2.3B
Average market cap$77.2B$37.5B
Average P/E19.723.2
Dividend / Share--0.29%


VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF
RYH Invesco S&P 500® Equal Weight Health Ca...


Top 5 Sectors
Portfolio weighting
Healthcare 98.99%
Consumer goods 1.01%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
PFE Pfizer23.45%
JNJ Johnson & Johnson21.99%
LLY Eli Lilly and Co4.78%
VTRS Viatris Inc4.60%
BMY Bristol-Myers Squibb4.57%
ZTS Zoetis Inc4.49%
MRK Merck4.42%
RPRX Royalty Pharma PLC4.30%
CTLT Catalent Inc4.24%
ELAN Elanco Animal Health Inc4.06%